** Epilepsy Research News: January 2021
------------------------------------------------------------
In this month’s epilepsy research news, we share two studies that have identified potential new mechanisms for preventing or treating seizures. The first study, conducted by CURE Epilepsy grantee Dr. John Swann and colleagues, uses an animal model of severe epileptic spasms ([link removed]) to reveal a particular type of brain cell important in the generation of these spasms. The second study investigates the role of the brain’s neuronal support system ([link removed]) in managing brain hyperexcitability, such as that seen in epilepsy.

We also report an advance in the ability to forecast the probability of seizures ([link removed]) , sometimes days in advance, using an implantable device. Another study finds that pregnant women with epilepsy ([link removed]) do not have an increased seizure rate during pregnancy as long as their medication levels are carefully monitored.

Finally, we highlight a study finding a slightly increased risk of COVID-19 hospital admission and death ([link removed]) in individuals with epilepsy who also have other risk factors or specific health conditions.  

Summaries of these research discoveries are below.
Research Highlights
* Understanding Epileptic Spasms (Featuring the work of CURE Epilepsy grantee Dr. John Swann): In work partially funded by CURE Epilepsy’s Infantile Spasms Initiative, CURE Epilepsy Grantee Dr. John Swann and colleagues found evidence that severe epileptic spasms originate from a specific cell type located in the frontal lobe of the brain. The study also revealed that brain activity immediately before epileptic spasms closely resembles a phase of the sleep cycle, highlighting potential avenues to prevent these spasms from occurring. Learn more ([link removed])

* Immune Cells and Seizure Prevention: A recent study has found that microglia, cells that are an important part of the brain's immune system, help prevent brain hyperexcitability (which can lead to seizures) by constantly surveilling their environment through a process that involves extending and retracting "branches" from their cell body. These findings could open new therapeutic avenues for epilepsy, which is characterized by hyperexcitability of neurons in the brain. Learn More ([link removed])

* Forecasting Epilepsy: A new study has found that seizure probability can be forecasted days in advance by using a particular type of data recorded with an implanted device that monitors brain activity. The study, which analyzed data collected during a trial of participants who had an FDA-approved, implanted neurostimulation device, raises the possibility of eventually providing epilepsy patients with seizure forecasts that could predict the likelihood that a seizure will occur days in advance. Learn More ([link removed])

* Epilepsy and Pregnancy: Women with epilepsy do not have an increased seizure rate during pregnancy as long as they have their medication levels carefully monitored, a new study suggests. The study showed similar fluctuations in seizure rates in women with epilepsy during pregnancy to seizure rates in a group of women with epilepsy who were not pregnant. Learn More ([link removed])

* Epilepsy and COVID-19 Risk: There is a slightly increased risk of hospital admission and death from COVID-19 in people with epilepsy, according to a new study. The research looked at risk factors for hospital admissions and death from COVID-19 in more than 6 million adults across England. The researchers found a small increase in risk of hospital admissions and deaths resulting from COVID-19 in both men and women with epilepsy and other risk factors such as Down Syndrome and sickle cell disease. Learn More ([link removed])

[link removed] the latest updates on epilepsy research anytime, anywhere, in the palm of your hand with the CURE Epilepsy Research Mobile App!
iOS ([link removed]) | Android ([link removed])
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed]
[link removed]
[link removed]-
[link removed]
[link removed]

============================================================
Copyright © 2021 CURE Epilepsy, All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.

Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
CURE Epilepsy . 420 Wabash Ave, Ste 650 . Chicago, IL 60611 . USA